GlassScriptPhysician profile
Gary S Gossen
NPI 1124091079
$2,054.27
in general payments reported to CMS, 2019-2025
24 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $295 · 2021: $310 · 2022: $189 · 2023: $236 · 2024: $99.54 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $390.38 | 2019-2025 | Tremfya |
| Abbvie INC. | $381.85 | 2020-2025 | |
| Allergan, INC. | $198.89 | 2019-2020 | |
| Ucb, INC. | $161.49 | 2019-2020 | |
| Genzyme Corporation | $139.10 | 2023-2025 | |
| Pfizer INC. | $118.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.46 | 2021-2025 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $79.84 | 2019-2020 | |
| Celgene Corporation | $59.39 | 2021-2022 | |
| Intuitive Surgical, INC. | $47.79 | 2024 | |
| Phathom Pharmaceuticals, INC. | $41.24 | 2025 | Voquezna |
| Shionogi INC | $40.93 | 2019 | |
| Nestle Healthcare Nutrition INC. | $38.32 | 2022 | |
| Amgen INC. | $35.47 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $33.21 | 2025 | Zenpep |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $30.43 | 2020 | |
| Angiodynamics, INC. | $23.52 | 2023 | Auryon Laser System 100-120 Vac |
| Shire North American Group INC | $22.21 | 2019 | |
| Biocon Biologics INC | $21.47 | 2025 | Yesintek |
| Ardelyx, INC. | $21.07 | 2024 | Ibsrela |
| Vivus LLC | $19.95 | 2021 | |
| Intercept Pharmaceuticals, INC. | $16.52 | 2022 | |
| Merck Sharp & Dohme LLC | $16.13 | 2023 | Dificid |
| Evoke Pharma, INC. | $16.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Gossen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.